Nutra Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	-	-	-	0.09	-	-
Short-Term Investments	0.02	0.04	-	-	-	-
Cash & Short-Term Investments	0.02	0.04	-	0.09	-	-
Accounts Receivable	0.02	0.02	0.02	0.05	0.04	0.03
Other Receivables	0.05	0.04	-	0.01	0	-
Receivables	0.09	0.07	0.25	0.33	0.04	0.03
Inventory	0.02	0.02	0.02	0.03	0.01	0.01
Prepaid Expenses	0.03	0.03	0.06	0.07	0.01	0.01
Other Current Assets	0.16	0.16	-	0.02	-	0.01
Total Current Assets	0.31	0.31	0.33	0.53	0.06	0.06
Property, Plant & Equipment	0.12	0.19	0.33	0.14	0.16	0.21
Other Long-Term Assets	0.12	0.13	0.09	0.11	0.09	0.07
Total Assets	0.56	0.64	0.75	0.78	0.3	0.34
Accounts Payable	0.84	0.76	0.73	0.67	0.6	0.58
Accrued Expenses	3.16	2.76	2.36	2.05	2.39	2.02
Short-Term Debt	3.38	2.75	2.07	4.42	2.26	6.09
Current Portion of Long-Term Debt	6.07	6.24	5.98	3.38	2.59	1.39
Current Portion of Leases	0.09	0.08	0.07	0.08	0.08	0.07
Current Unearned Revenue	0.29	0.23	0.18	-	-	-
Other Current Liabilities	1.38	1.34	1.31	10.54	3.57	0.84
Total Current Liabilities	15.21	14.17	12.7	21.14	11.48	10.99
Long-Term Debt	0.14	0.14	0.25	0.52	0.25	0.91
Long-Term Leases	0.02	0.09	0.18	-	0.06	0.14
Total Liabilities	15.38	14.41	13.13	21.66	11.8	12.04
Common Stock	7.1	7.06	7.04	6.77	6.96	5.88
Additional Paid-In Capital	53.6	53.63	53.65	53.6	50.18	50.28
Retained Earnings	-76	-74.95	-73.55	-81.73	-68.63	-67.86
Comprehensive Income & Other	0.47	0.47	0.47	0.47	-	-
Total Common Equity	-14.83	-13.78	-12.39	-20.89	-11.5	-11.7
Shareholders' Equity	-14.82	-13.77	-12.38	-20.88	-11.49	-11.7
Total Liabilities & Equity	0.56	0.64	0.75	0.78	0.3	0.34
Total Debt	9.71	9.31	8.55	8.4	5.24	8.6
Net Cash (Debt)	-9.69	-9.27	-8.55	-8.3	-5.24	-8.6
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	7,100	7,100	7,100	7,364	7,268	7,260
Total Common Shares Outstanding	7,100	7,065	7,040	7,331	6,955	5,877
Working Capital	-14.9	-13.86	-12.37	-20.61	-11.43	-10.93
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-14.83	-13.78	-12.39	-20.89	-11.5	-11.7
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Machinery	0.06	0.06	0.25	0.19	0.15	0.14
Leasehold Improvements	-	-	0.07	0.07	0.07	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.